期刊文献+

厄贝沙坦联合苯磺酸氨氯地平治疗老年糖尿病合并高血压伴高尿酸血症临床评价思考 被引量:10

Clinical Evaluation Of Irbesartan Combined with Amlodipine Besylate in the Treatment of Senile Diabetes with Hypertension and Hyperuricemia
在线阅读 下载PDF
导出
摘要 目的分析厄贝沙坦联合苯磺酸氨氯地平治疗老年糖尿病合并高血压伴高尿酸血症的临床疗效及应用价值。方法选取105例老年糖尿病合并高血压伴高尿酸血症患者作为研究对象,采用随机分组法均分为3组,将单纯使用厄贝沙坦进行治疗的患者作为厄贝沙坦组;将单纯使用苯磺酸氨氯地平治疗的患者作为苯磺酸氨氯地平组;将采用上述两种药物进行联合治疗的患者作为联合组。分析并对比三组不同用药方案下血压、血尿酸水平变化的差异。结果联合组治疗总有效率显著高于厄贝沙坦组与苯磺酸氨氯地平组(P<0.05);三组经治疗后血压水平均显著降低,联合组降低程度显著高于其他两组(P<0.05);联合组与厄贝沙坦组经治疗后血尿酸水平均显著降低(P<0.05)。结论针对糖尿病合并高血压伴高尿酸血症的老年患者进行临床治疗时,采用厄贝沙坦与苯磺酸氨氯地平联合用药可有效改善患者多项临床症状,疗效较为显著,且安全性较高,值得临床推广应用。 Objective To analyze the clinical efficacy and value of irbesartan combined with amlodipine besylate in the treatment of diabetes mellitus complicated with hypertension and hyperuricemia. Methods 105 patients with senile urinary disease complicated with hypertension and hyperuricemia were selected as study subjects and randomly divided into 3 groups. Patients treated with irbesartan alone were treated as irbesartan group; Patients treated with amlodipine besylate were treated as amlodipine besylate group; patients who were treated with the combination of the above two drugs were used as a combination group. Analyze and contrast the differences in blood pressure and blood uric acid levels among the three groups of different drug regimens. Results The total effective rate of the combined group was significantly higher than that of the irbesartan group and the amlodipine besylate group(P〈0.05); The blood pressure levels of the three groups after treatment were significantly lower, and the degree of reduction in the combined group was significantly higher than that of the other two groups(P〈0.05); The uric acid levels in the combination group and irbesartan group were significantly lower(P〈0.05). Conclusion In the clinical treatment of elderly patients with diabetes mellitus complicated with hypertension and hyperuricemia, the combination of irbesartan and amlodipine besylate can effectively improve the patient's clinical symptoms, the efficacy is more significant, and the safety is higher, worthy of clinical application.
作者 李玲 LI Ling(The Sixth Community Health Service Center of Shihezi,Shihezi,Xinjiang,83200)
出处 《智慧健康》 2018年第10期69-71,共3页 Smart Healthcare
关键词 厄贝沙坦 苯磺酸氨氯地平 糖尿病 高血压 Irbesartan Amlodipine besylate Diabetes Hypertension
  • 相关文献

参考文献11

二级参考文献94

  • 1陈超.厄贝沙坦联合苯磺酸氯地平治疗老年糖尿病高血压合并高尿酸血症患者的疗效[J].中国老年学杂志,2014,34(11):2946-2948. 被引量:33
  • 2Droumaguet C,Balkau B,Simon D,et al.Use of HbAlc in predicting progression to diabetes in French men and women:data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).Diabetes Care,2006,29:1619-1625.
  • 3HAPO Study Cooperative Research Group,Metzger BE,Lowe LP,et al.Hyperglycemia and adverse pregnancy outcomes.N Engl J Med,2008,358:1991-2002.
  • 4van den Berg,he G,Wouters P,Weekers F,et al.Intensive insulin therapy in the critically ill patients.N Engl J Med,2001,345:1359-1367.
  • 5Antithrombotic Trialists' (ATT) Collaboration.Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomised trials.Lancet,2009,373:1849-1860.
  • 6Ogawa H,Nakayama M,Morimoto T,et al.Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2diabetes:a randomized controlled trial.JAM A,2008,300:2134-2141.
  • 7Belch J,MacCuish A,Campbell I,et al.The prevention of progression of arterial disease and diabetes (POPADAD) trial:factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.BMJ,2008,337:a1840.
  • 8Coleman K,Austin BT,Brach C,et al.Evidence on the chronic care model in the new millennium.Health Aff (Millwood),2009,28:75-85.
  • 9Borch-Johnsen K,Colagiuri S.DETECT-2:early detection of type 2 diabetes and IGT.Diabetes Voice,2003,48(4):11-13.
  • 10Szel6nyi Z, Fazakas A, Szendsi G, et al. The mechanism ol reducedlongitudinal left ventricular systoHc function in hypertensivepatients with normal ejection frac;tion[J]. J Hypertens, 2015, 33(9):1962-1969.

共引文献4784

同被引文献77

引证文献10

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部